Novel direct detection method for quantitative determination of intracellular nucleoside triphosphates using weak anion exchange liquid chromatography/tandem mass spectrometry. 2002

Guoen Shi, and Jing-tao Wu, and Yu Li, and Romas Geleziunas, and Karen Gallagher, and Tom Emm, and Timothy Olah, and Steve Unger
Discovery Metabolism and Pharmacokinetics, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, Experimental Station, E353/110A, P.O. Box 80353, Wilmington, DE 19880, USA. guoen.shi@bms.com

A novel analytical method has been developed for direct quantification of intracellular nucleoside triphosphates (NTPs). Lysates of human peripheral blood mononuclear cells (PBMCs) were extracted by protein precipitation, and the filtered extracts were analyzed by weak anion exchange liquid chromatography (WAX-LC) coupled to detection by mass spectrometry (MS). Compared with ion pairing (IP)-LC/MS/MS, the only MS-compatible direct detection method for NTPs currently available, the new method completely avoids the usage of ion-pairing reagents and has a shorter analytical time of only 2 min. The method was validated and is being used to determine the amount of the triphosphate metabolite of D-D4FC (DPC817), an investigational HIV nucleoside reverse transcriptase inhibitor (NRTI), in human PBMC samples from clinical studies. By using a PE Sciex API 4000 triple quadrupole instrument operating in positive ion MRM mode, the method was able to achieve a lower limit of quantitation (LLOQ) of 5 fmol/10(6) cells in samples containing 3 x 10(6) lysed cells (6 fmol on-column). With minor adaptation, the method described here may be suitable for analyzing other NTPs. This paper also provides a discussion of the unique retention characteristics of WAX-LC, the principles of which may prove to be valuable for designing other forms of directly coupled ion-exchange (IX)-LC/MS methods suited for high sensitivity quantitative analysis.

UI MeSH Term Description Entries
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D003570 Cytidine Triphosphate Cytidine 5'-(tetrahydrogen triphosphate). A cytosine nucleotide containing three phosphate groups esterified to the sugar moiety. CTP,CRPPP,Magnesium CTP,Mg CTP,Triphosphate, Cytidine
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D016047 Zalcitabine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication at low concentrations, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal toxic side effect is axonal degeneration resulting in peripheral neuropathy. 2',3'-Dideoxycytidine,Dideoxycytidine,ddC (Antiviral),HIVID Roche,Hivid,NSC-606170,2',3' Dideoxycytidine,NSC 606170,NSC606170
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Guoen Shi, and Jing-tao Wu, and Yu Li, and Romas Geleziunas, and Karen Gallagher, and Tom Emm, and Timothy Olah, and Steve Unger
December 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Guoen Shi, and Jing-tao Wu, and Yu Li, and Romas Geleziunas, and Karen Gallagher, and Tom Emm, and Timothy Olah, and Steve Unger
December 2006, Clinical chemistry,
Guoen Shi, and Jing-tao Wu, and Yu Li, and Romas Geleziunas, and Karen Gallagher, and Tom Emm, and Timothy Olah, and Steve Unger
August 2011, Journal of chromatography. A,
Guoen Shi, and Jing-tao Wu, and Yu Li, and Romas Geleziunas, and Karen Gallagher, and Tom Emm, and Timothy Olah, and Steve Unger
January 2018, Genes and environment : the official journal of the Japanese Environmental Mutagen Society,
Guoen Shi, and Jing-tao Wu, and Yu Li, and Romas Geleziunas, and Karen Gallagher, and Tom Emm, and Timothy Olah, and Steve Unger
December 2006, Journal of mass spectrometry : JMS,
Guoen Shi, and Jing-tao Wu, and Yu Li, and Romas Geleziunas, and Karen Gallagher, and Tom Emm, and Timothy Olah, and Steve Unger
August 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Guoen Shi, and Jing-tao Wu, and Yu Li, and Romas Geleziunas, and Karen Gallagher, and Tom Emm, and Timothy Olah, and Steve Unger
July 2000, Analytical biochemistry,
Guoen Shi, and Jing-tao Wu, and Yu Li, and Romas Geleziunas, and Karen Gallagher, and Tom Emm, and Timothy Olah, and Steve Unger
December 2020, Therapeutic drug monitoring,
Guoen Shi, and Jing-tao Wu, and Yu Li, and Romas Geleziunas, and Karen Gallagher, and Tom Emm, and Timothy Olah, and Steve Unger
December 2004, Clinical chemistry,
Guoen Shi, and Jing-tao Wu, and Yu Li, and Romas Geleziunas, and Karen Gallagher, and Tom Emm, and Timothy Olah, and Steve Unger
June 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Copied contents to your clipboard!